You have 9 free searches left this month | for more free features.

City

Condition

Breast Cancer (1)

Cancer of Colon (1)

Cancer of Pancreas (1)

Cancer, Breast (1)

Cancer, Lung (1)

Cancer, Ovarian (1)

Lung Cancer (1)

Lymphoma, Non-Hodgkin (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Phase

Sponsor

Biologics & Biosimilars Collective Intelligence Consortium (1)

Catherine M. Lockhart (1)

Collaborator

Harvard Pilgrim Health Care (2)

HealthPartners Institute (2)

Aetna, Inc. (1)

Amgen (1)

College of Pharmacy, University of Nebraska College (1)

College of Pharmacy, University of New England (1)

Henry Ford Health System (1)

Momenta Pharmaceuticals, Inc. (1)

Intervention

filgrastim, tbo-filgrastim or pegfilgrastim (1)

receipt of granulocyte-colony stimulating factor (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Observational (2)

bbcic

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

G-CSF Use in Breast Cancer, Lung Cancer, or Lymphoma Treated

Completed

Breast Cancer
Lung Cancer

filgrastim, TBO-filgrastim or pegfilgrastim

(no location specified)

Jul 24, 2021

Granulocyte Colony Stimulating Factor Originator Products Versus

Active, not recruiting

Cancer, Breast
+5 more

Receipt of granulocyte-colony stimulating factor

(no location specified)

Jul 24, 2021